Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Valentina Marulanda Corzo
Observed names:
V. Marulanda Corzo,
V. Marulanda-Corzo,
Valentina Marulanda-Corzo,
Valentina Marulanda‐Corzo
Institutions:
NewYork–Presbyterian Hospital,
Cornell University,
Weill Cornell Medicine,
Weill Cornell Medical Center
Observed institutions:
NewYork–Presbyterian Hospital,
Oregon Health & Science University,
Cornell University,
Weill Cornell Medicine,
Weill Cornell Medical Center,
University of Pennsylvania
show all 6
ORCID:
0009-0005-1693-3854
Observed ORCID:
0009-0005-1693-3854
OpenAlex ID:
A5068853657
Clinical Utility of [ 18 F]-Fluciclovine PET/MRI for Differentiating True Progression from Treatment-Related Changes in Patients with Glioblastoma
2025
·
Jana Ivanidze
, Kellen Vo Vu
, et al.
·
American Journal of Neuroradiology
·
9
Long-term outcomes of active surveillance after DOTATATE PET/MRI–confirmed gross total resection in WHO grade 2 meningioma
2025
·
Jana Ivanidze
, Kellen Vo Vu
, et al.
·
Neuro-Oncology Advances
·
4
How Will PSMAddition Impact the Management of Prostate Cancer?
2026
·
Valentina Marulanda-Corzo
, Aaron N. Holmes
, et al.
·
European Urology Focus
·
3
A Phase I Dose-Escalation/Expansion Study of Fractionated-Dose and Multiple-Cycle Anti–PSMA-Targeted α-Emitter 225Ac-J591 in Patients with Prostate Cancer
2026
·
Scott T. Tagawa
, Charlene Thomas
, et al.
·
Clinical Cancer Research
·
2
PDF
2396P Dose-escalation + expansion trial of fractionated and multiple-dose PSMA-targeted alpha radionuclide 225Ac-J591 for mCRPC
2025
·
S.T. Tagawa
, C. Thomas
, et al.
·
Annals of Oncology
·
2
PSMA-targeted actinium-225 therapy in metastatic castration-resistant prostate cancer (mCRPC): Baseline and follow-up PSMA PET parameters associated with outcomes.
2025
·
Valentina Marulanda Corzo
, Charlene Thomas
, et al.
·
Journal of Clinical Oncology
·
2
Revolutionizing prostate cancer treatment: PSMA-targeted therapy in modern therapeutics
2025
·
A. Ricaurte-Fajardo
, V. Marulanda-Corzo
, et al.
·
Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)
·
2
Stereotactic Body Radiation Therapy (SBRT)-Induced 68Ga-PSMA PET Bone Flare
2026
·
Valentina Marulanda-Corzo
, Preeti Kakkar
, et al.
·
Clinical Nuclear Medicine
·
1
Imaging meets genomics in treatment-naïve prostate cancer: SUVmax on prostate-specific membrane antigen (PSMA) PET as a biomarker of genomic classifier risk.
2026
·
Sophia Coraci
, Valentina Marulanda Corzo
, et al.
·
Journal of Clinical Oncology
·
1
RADT-15 Utility of [Ga68] DOTATATE PET/MRI-Guided SSTR-positive volume for meningioma response assessment after stereotactic radiosurgery
2026
·
Joseph Adedigba
, Valentina Marulanda Corzo
, et al.
·
Neuro-Oncology
Supplementary Figure S2 from A Phase I Dose-Escalation/Expansion Study of Fractionated-Dose and Multiple-Cycle Anti–PSMA-Targeted α-Emitter 225Ac-J591 in Patients with Prostate Cancer
2026
·
Scott T. Tagawa
, Charlene Thomas
, et al.
Supplementary Methods S1 from A Phase I Dose-Escalation/Expansion Study of Fractionated-Dose and Multiple-Cycle Anti–PSMA-Targeted α-Emitter 225Ac-J591 in Patients with Prostate Cancer
2026
·
Scott T. Tagawa
, Charlene Thomas
, et al.
Supplementary Table S7 from A Phase I Dose-Escalation/Expansion Study of Fractionated-Dose and Multiple-Cycle Anti–PSMA-Targeted α-Emitter 225Ac-J591 in Patients with Prostate Cancer
2026
·
Scott T. Tagawa
, Charlene Thomas
, et al.
Data from A Phase I Dose-Escalation/Expansion Study of Fractionated-Dose and Multiple-Cycle Anti–PSMA-Targeted α-Emitter 225Ac-J591 in Patients with Prostate Cancer
2026
·
Scott T. Tagawa
, Charlene Thomas
, et al.
Supplementary Figure S4 from A Phase I Dose-Escalation/Expansion Study of Fractionated-Dose and Multiple-Cycle Anti–PSMA-Targeted α-Emitter 225Ac-J591 in Patients with Prostate Cancer
2026
·
Scott T. Tagawa
, Charlene Thomas
, et al.
Supplementary Table S4 from A Phase I Dose-Escalation/Expansion Study of Fractionated-Dose and Multiple-Cycle Anti–PSMA-Targeted α-Emitter 225Ac-J591 in Patients with Prostate Cancer
2026
·
Scott T. Tagawa
, Charlene Thomas
, et al.
Supplementary Table S2 from A Phase I Dose-Escalation/Expansion Study of Fractionated-Dose and Multiple-Cycle Anti–PSMA-Targeted α-Emitter 225Ac-J591 in Patients with Prostate Cancer
2026
·
Scott T. Tagawa
, Charlene Thomas
, et al.
Supplementary Table S1 from A Phase I Dose-Escalation/Expansion Study of Fractionated-Dose and Multiple-Cycle Anti–PSMA-Targeted α-Emitter 225Ac-J591 in Patients with Prostate Cancer
2026
·
Scott T. Tagawa
, Charlene Thomas
, et al.
Supplementary Table S6 from A Phase I Dose-Escalation/Expansion Study of Fractionated-Dose and Multiple-Cycle Anti–PSMA-Targeted α-Emitter 225Ac-J591 in Patients with Prostate Cancer
2026
·
Scott T. Tagawa
, Charlene Thomas
, et al.
Supplementary Table S3 from A Phase I Dose-Escalation/Expansion Study of Fractionated-Dose and Multiple-Cycle Anti–PSMA-Targeted α-Emitter 225Ac-J591 in Patients with Prostate Cancer
2026
·
Scott T. Tagawa
, Charlene Thomas
, et al.
Supplementary Figure S1 from A Phase I Dose-Escalation/Expansion Study of Fractionated-Dose and Multiple-Cycle Anti–PSMA-Targeted α-Emitter 225Ac-J591 in Patients with Prostate Cancer
2026
·
Scott T. Tagawa
, Charlene Thomas
, et al.
Supplementary Table S5 from A Phase I Dose-Escalation/Expansion Study of Fractionated-Dose and Multiple-Cycle Anti–PSMA-Targeted α-Emitter 225Ac-J591 in Patients with Prostate Cancer
2026
·
Scott T. Tagawa
, Charlene Thomas
, et al.
Supplementary Figure S3 from A Phase I Dose-Escalation/Expansion Study of Fractionated-Dose and Multiple-Cycle Anti–PSMA-Targeted α-Emitter 225Ac-J591 in Patients with Prostate Cancer
2026
·
Scott T. Tagawa
, Charlene Thomas
, et al.
Opportunistic Screening for Cardiovascular and Chronic Obstructive Pulmonary Disease Biomarkers and Implications for Downstream Care: A Retrospective Lung Cancer Screening Cohort Study
2026
·
Lauren K. Groner
, Maria Patricia Puello
, et al.
·
Journal of the American College of Radiology
Nira-11 [f18]fluciclovine Pet and Dce-mri in the Evaluation of Recurrence Vs Treatment Effect in Previously Radiated Intracranial Metastases
2026
·
Kate Rosen
, Valentina Marulanda Corzo
, et al.
·
Neuro-Oncology Advances
Show more works
View as search
Works count:
38
Citation count:
26
H-index:
3
I10-index:
Year
Topic
Type